Hemply Balance (HMPLY) Q4 2025 earnings summary

Executive summary

• Net sales for Q4 2025 increased 198.2% year-over-year to 343 TSEK, driven by orders from the Japanese distributor.

• Full-year 2025 net sales declined 28.0% to 838 TSEK, mainly due to discontinued e-commerce sales active in 2024.

• Significant cost adjustments in 2025 led to improved results, with EBITDA loss narrowing to -470 TSEK from -613 TSEK year-over-year.

• No major events occurred in Q4 or after year-end; strategic focus remains on a potential reverse acquisition.

Financial highlights

• Q4 2025 gross profit was 264 TSEK (up from 215 TSEK), with a gross margin of 76.9%.

• Full-year gross profit was 605 TSEK (down from 1,006 TSEK), gross margin 72.2%.

• Q4 EBITDA was -2 TSEK (improved from -20 TSEK); full-year EBITDA was -470 TSEK (improved from -613 TSEK).

• Net result for Q4 was -3 TSEK (improved from -19 TSEK); full-year net result was -474 TSEK (improved from -611 TSEK).

• Cash flow from operations for 2025 was -263 TSEK (down from 2,108 TSEK in 2024); cash at year-end was 220 TSEK.

Outlook and guidance

• Strategic focus continues to be on executing a reverse acquisition to create long-term shareholder value.

• Additional orders from the Japanese distributor have been received in Q1 2026.